Products for markers of Neurodegenerative diseases
Antibodies for alpha-Synuclein
The portfolio includes antibodies against different sites of alpha-Synuclein as well as the pathological beta-sheet form of alpha-Synuclein.
Antibodies for Disease related proteins
Well characterized MAbs for enzymes involved in inflammatory processes in relation to neurological changes including degeneration of nervous tissue.
Antibodies for Neurofilament Light Chain (NfL)
New monoclonal antibodies are available Neurofilament Light Chain (NfL).
Antibodies for prions
Well established and tested antibodies to different binding sites of bovine and human prion protein are available
Antibodies for TDP43
New monoclonal antibodies for protein 43 (TDP43) directed to different epitopes of N- and C-terminus as well as inside center of the molecule
BetaPrion HUMAN ELISA
Enzyme immunoassay for the quantitative determination of human prion protein in human CSF as well as in plasma and serum.
hSYN total ELISA
Enzyme immunoassay for quantitative determination of alpha-Synuclein in human CSF
hTAU total ELISA CE-IVD
Enzyme immunoassay CE-IVD for quantitative determination of human TAU in human CSF supporting the diagnosis of Alzheimer’s disease
Human alpha-Synuclein PATHO ELISA
Enzyme immunoassay for the quantitative determination of beta-sheet oligomers of human alpha-Synuclein in biological samples.
Human P231 TAU ELISA
Enzyme immunoassay for quantitative determination of amino acid 231 (T) phosphorylated human TAU in biological samples.
Human TAU AGGREGATE ELISA
Enzyme immunoassay for quantitative determination of human TAU aggregates in human and animal tissue samples and in cell cultures.
non-pTAU ELISA CE-IVD
Enzyme immunoassay for quantitative determination of a non-phosphorylated TAU fraction in human CSF supporting the diagnosis of Alzheimer’s disease
- 1
- 2
